BMX-010

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBMX-010
Drug Alias NameBMX-010MnTE-2-PyP5+MnTE-2-PyP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase modulatorsHypoxia-inducible factor 1 alpha inhibitors
TargetsHypoxia-inducible factor 1 alphaSuperoxide dismutase
Therapy Area/IndicationsPsoriasisRosaceaAcne Vulgaris +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDuke University
China Registration ClassN/A

Develop Information

Active CompaniesBiomimetixBiomimetix Jv Llc
Inactive CompaniesN/A
Active IndicationsPsoriasisDermatitis, Atopic
Inactive IndicationsRosaceaAcne Vulgaris

Other Information

ATC CodeN/A
Related LinksN/A